Drug Profile
Amphotericin B lipid nanosphere - Nippon Shinyaku
Alternative Names: NS 718Latest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Nippon Shinyaku
- Class Antifungals; Antiprotozoals; Antipyretics; Macrolides
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cryptococcosis
Most Recent Events
- 05 Jan 2000 Phase-II clinical trials for Cryptococcosis in Japan (Unknown route)
- 30 Dec 1998 Preclinical development for Cryptococcosis in Japan (Unknown route)